Literature DB >> 6113770

New data on lithium and haloperidol incompatibility.

G Spring, M Frankel.   

Abstract

The authors describe a case of combined lithium and haloperidol toxicity characterized by hyperpyrexia, severe rigidity, mutism, and development of irreversible tardive dyskinesia. This case is similar to four other cases described in the literature and to the neuroleptic malignant syndrome. The authors postulate that two types of combined lithium-neuroleptic toxicity occur: a neuroleptic malignant extrapyramidal syndrome and a lithium toxicity that occurs in combination with phenothiazines, primarily thioridazine. Possible mechanisms and preventive measures are discussed.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6113770     DOI: 10.1176/ajp.138.6.818

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  7 in total

1.  Neurotoxicity with combined use of lithium and haloperidol decanoate.

Authors:  Michelle D Colvard; John D Gentry; Diana M Mullis
Journal:  Prim Care Companion CNS Disord       Date:  2013

2.  Cerebellar syndrome in lithium poisoning.

Authors:  D E Jacome
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-12       Impact factor: 10.154

3.  [Neurotoxic encephalopathy caused by neuroleptics and lithium].

Authors:  E Lambreva; M Vecellio; H G Wieser; C Buddeberg
Journal:  Nervenarzt       Date:  2005-06       Impact factor: 1.214

4.  Effect of chronic lithium treatment with or without haloperidol on number and sizes of neurons in rat neocortex.

Authors:  R W Licht; J O Larsen; D Smith; H Braendgaard
Journal:  Psychopharmacology (Berl)       Date:  1994-07       Impact factor: 4.530

5.  Recovery and rechallenge after the neuroleptic malignant synorome.

Authors:  M P Chopra; R Raguram
Journal:  Indian J Psychiatry       Date:  2001-01       Impact factor: 1.759

Review 6.  Clinical relevance of drug interactions with lithium.

Authors:  P R Finley; M D Warner; C A Peabody
Journal:  Clin Pharmacokinet       Date:  1995-09       Impact factor: 6.447

7.  Increased risk of occurrence of neuroleptic malignant syndrome on combined treatment with lithium and neuroleptic.

Authors:  P J Alexander; R M Thomas
Journal:  Indian J Psychiatry       Date:  1997-07       Impact factor: 1.759

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.